News

• J&J posts Q2 EPS of $1.8, dropping 23.4% YoY
  07/19/2022 / 12:26 - TeleTrader
•  
• FDA limits J&J vaccine use due to blood clot risks
  05/06/2022 / 02:58 - TeleTrader
•  
• J&J's Q1 sales up 5% YoY to $23.4B
  04/19/2022 / 12:27 - TeleTrader
•  
• CDC confirms additional boosters for over-50s
  03/29/2022 / 22:41 - TeleTrader
•  
• Johnson: Putin must know he would pay high price for invasion
  02/19/2022 / 11:37 - TeleTrader
•  
• Top NoSQL Innovators Honored with ScyllaDB Awards
  02/16/2022 / 14:58 - GlobeNewswire
•  
• Report: J&J quietly paused COVID vaccine production
  02/08/2022 / 17:01 - TeleTrader
•  
• J&J Q4 EPS soars 172.3% to $1.77
  01/25/2022 / 12:31 - TeleTrader
•  
• J&J booster 85% effective against hospitalization in S. Africa
  12/30/2021 / 13:24 - TeleTrader
•  
• Switzerland approves J&J booster
  12/27/2021 / 15:59 - TeleTrader
•  
• S. Africa to start rollout of vaccine boosters today
  12/24/2021 / 09:45 - TeleTrader
•  
• J&J, Sputnik V, Sinopharm jabs weaker against Omicron - study
  12/17/2021 / 13:09 - TeleTrader
•  
• CDC recommends mRNA vaccines over J&J
  12/16/2021 / 20:52 - TeleTrader
•  
• Guardion Health Sciences Issues Letter to Shareholders
  12/16/2021 / 14:00 - GlobeNewswire
•  
• CDC to consider restricting J&J's COVID jab - report
  12/16/2021 / 06:55 - TeleTrader